Danish national registry data suggest adults with type 2 diabetes taking SGLT2 inhibitors have a slightly lower risk of developing diabetic foot problems than those taking GLP-1 receptor agonists.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/sglt2-inhibitors-linked-lower-neuropathy-risk-danish-study-2026a10002fl?src=rss
Author :
Publish date : 2026-01-26 15:52:00
Copyright for syndicated content belongs to the linked Source.
